Yakira Capital Management’s Deep Medicine Acquisition Corp. Rights DMAQR Stock Holding History

Yakira Capital Management’s Portfolio DMAQR Stock Details DMAQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-489,668	Closed	-$147K	–	361
2023 Q4	$147K	Sell	489,668 -149,869	-23%	-$46.3K	0.05%	135
2023 Q3	$223K	Sell	639,537 -110,458	-15%	-$29.1K	0.06%	137
2023 Q2	$127K	Sell	749,995 -5	-0%	-$1	0.03%	151
2023 Q1	$109K	Hold	750,000	–	–	0.03%	166
2022 Q4	$45K	Hold	750,000	–	–	0.01%	206
2022 Q3	$29K	Hold	750,000	–	–	﹤0.01%	301
2022 Q2	$83K	Hold	750,000	–	–	0.01%	271
2022 Q1	$135K	Hold	750,000	–	–	0.02%	314
2021 Q4	$240K	Buy	+750,000	New	+$237K	0.03%	292

Yakira Capital Management's DMAQR Position: Q1 2024 in Review

Yakira Capital Management sold out of Deep Medicine Acquisition Corp. Rights (DMAQR) in Q1 2024, closing a stake of 489,668 shares — an estimated $147K sold.

Yakira Capital Management first reported a position in DMAQR in Q4 2021 and held it in 9 quarters. The position peaked at $240K in Q4 2021. 0 funds tracked by Wall St. Rank hold DMAQR as of Q1 2024.

Yakira Capital Management reported no remaining Deep Medicine Acquisition Corp. Rights position as of Q1 2024 after selling out during the quarter.
Yakira Capital Management sold 489,668 Deep Medicine Acquisition Corp. Rights shares in Q1 2024, an estimated $147K.
Yakira Capital Management first reported a position in Deep Medicine Acquisition Corp. Rights in Q4 2021 and held it in 9 quarters.
Yakira Capital Management's Deep Medicine Acquisition Corp. Rights position peaked at $240K in Q4 2021.
0 funds tracked by Wall St. Rank held Deep Medicine Acquisition Corp. Rights as of Q1 2024.

Based on Yakira Capital Management's 13F filing for Q1 2024, filed 14 May 2024.